Randomized Clinical Evaluation of Triple Antibiotic Paste, Modified TAP, and Metapex in Treating Infected Primary Molars with Poor Prognosis

Comparative evaluation of the clinical and radiographic success rates of Triple antibiotic paste, modified triple antibiotic paste and Metapex in the treatment of infected primary molars with poor prognosis: A Randomized clinical study. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093421

Enrollment

Registered

2025-08-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K041- Necrosis of pulp Health Condition 2: K040- Pulpitis

Interventions

Intervention1: Modified triple antibiotic paste,: Ciprofloxacin 500mg Metronidazole 400mg Doxycycline 200mg Cefixime 200mg all the Tablets will be crushed in morter pestle and then will be mixed w

Eligibility

Inclusion criteria

Inclusion criteria: Primary molars selected in this study will be based on clinical and radiographic screening. 1. Pulpally involved primary teeth (nonvital) 2. Gingival abscess, presence of fistula 3. Failed pulpotomy 4. Teeth with radiographic evidence of internal or external root resorption 5. Furcation or periapical radiolucency. 6. Excessive root resorption involving more than half of the root

Exclusion criteria

Exclusion criteria: 1. Teeth with pulpal floor perforation 2. Systemically compromised and patients with history of drug allergy

Design outcomes

Primary

Measure	Time frame
Resolution of pain, tenderness, mobility, clinicallyTimepoint: 1 week, 1 month, 3 months, 6months, 9 months, 12 months	—

Secondary

Measure	Time frame
Radiographic resolution of radiolucency.Timepoint: 3 months, 6months, 9 months, 12 months	—

Countries

India

Contacts

Public ContactDr Yash Jaju

JMFs ACPM Dental college and Hospital, Dhule

sandesh.bansal@gmail.com9689141996

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026